- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 489/02 - Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
Patent holdings for IPC class C07D 489/02
Total number of patents in this class: 298
10-year publication summary
|
27
|
23
|
17
|
14
|
7
|
10
|
8
|
2
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SpecGx LLC | 186 |
41 |
| Mallinckrodt LLC | 131 |
20 |
| Mallinckrodt Inc. | 135 |
16 |
| Zevra Therapeutics, Inc. | 99 |
13 |
| Nektar Therapeutics | 407 |
12 |
| Macfarlan Smith Limited | 93 |
11 |
| Rhodes Technologies | 57 |
10 |
| Tasmanian Alkaloids Pty Ltd. | 17 |
8 |
| Toray Industries, Inc. | 7096 |
7 |
| Purdue Pharma L.P. | 493 |
7 |
| Noramco, LLC | 28 |
7 |
| Dimerx, Inc. | 10 |
7 |
| Signature Therapeutics, Inc. | 37 |
6 |
| Brock University | 58 |
5 |
| Alere San Diego, Inc. | 62 |
4 |
| Euro-celtique S.A. | 86 |
4 |
| Progenics Pharmaceuticals, Inc. | 124 |
4 |
| The Scripps Research Institute | 1343 |
4 |
| Siegfried AG | 38 |
4 |
| Board of Regents, The University of Texas System | 6102 |
3 |
| Other owners | 105 |